Inventor · disambiguated record
Simon Mbua Ngale Efange
Also filed as: EFANGE SIMON M · EFANGE SIMON M N · EFANGE SIMON MBUA NGALE
10 granted patents·2 pending applications·127 citations·filing 1984–2021
90Inventor score
Top patents by PatentIndex Score
12 records- 0196US8742096B2Methods and compositions for preparing noribogaine from voacangineMORIARTY ROBERT M·Filed 2012·Granted Jun 3, 2014·24 cites·10 claims
- 0280US5789420AAzavesamicolsUNIV MINNESOTA·Filed 1993·Granted Aug 4, 1998·17 cites·2 claims
- 0369US5457207ASpirovesamicolsUNIV MINNESOTA·Filed 1993·Granted Oct 10, 1995·31 cites·1 claims
- 0458US4895937A5-ioso-2-pyrimidinone nucleosideUNIV NEW YORK STATE RES FOUND·Filed 1988·Granted Jan 23, 1990·9 cites·1 claims
- 0554US5338852AAzavesamicolsUNIV MINNESOTA·Filed 1992·Granted Aug 16, 1994·13 cites·6 claims
- 0654US2023132973A1DIHYDRO-SPIRO[INDOLINE-3:1'-iSOQUINOLIN]-2-ONES AS ANTIMALARIAL AGENTSTHE UNIV OF BUEA·Filed 2021·Application pending·0 cites
- 0752US5358712ARadiopharmaceutical agents for the detection of Alzheimer's diseaseUNIV MINNESOTA·Filed 1993·Granted Oct 25, 1994·14 cites·6 claims
- 0849US2022267329A1Dihydro-Spiro[Indoline-3:1'-Isoquinolin]-2-Ones and Their Analogues and Derivatives and Methods of Treating Cancer and Other DiseasesTHE UNIV OF BUEA·Filed 2020·Application pending·0 cites
- 0947US5876694AAzavesamicolsUNIV MINNESOTA·Filed 1997·Granted Mar 2, 1999·8 cites·2 claims
- 1046US4782142ANovel 5-substituted 2-pyrimidinone nucleosides and methods of useUNIV NEW YORK STATE RES FOUND·Filed 1984·Granted Nov 1, 1988·4 cites·3 claims
- 1137US5554752ASpirovesamicolsUNIV MINNESOTA·Filed 1995·Granted Sep 10, 1996·3 cites·1 claims
- 1236US5721243ARadiopharmaceutical agents for the detection of Alzheimers diseaseUNIV MINNESOTA·Filed 1994·Granted Feb 24, 1998·4 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Simon Mbua Ngale Efange files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →